Merck has made significant strides in the treatment of high cholesterol with the development of Enlicitide, an oral PCSK9 inhibitor…
Browsing: Mercks
Merck’s Keytruda Continues to Lead in Oncology As the patent for Keytruda approaches expiration, the world’s top-selling drug continues to…
Merck’s Keytruda Faces Competition with Subcutaneous Version Launch Merck & Co. is gearing up to face direct competition to its…
A recent milestone in the fight against respiratory syncytial virus (RSV) was achieved with the approval of Merck’s clesrovimab by…
Respiratory syncytial virus (RSV) has been a significant public health concern for vulnerable populations, especially infants, for many years. While…
